Categories: Analysis

Why Canopy Growth (CGC) might put investors in high spirits this year

For the cannabis industry, 2019 was a tough year though most companies started it on an optimistic note. With the year coming to an end, the market is currently pinning hope on cannabis 2.0 products and the expansion of store networks to give the market a new lease of life.

Also see: Beer firms expect new fizz from cannabis ventures?

While the marijuana boom continues to gather pace, several companies struggle with their piling up inventories, and Canopy Growth (NYSE: CGC) (TSX: WEED) is no exception. At the same time, the company has been building up its dried-flower inventory to monetize the growing demand for recreational cannabis in Canada. In the US, more states are legalizing pot-based products, which is expected to pick up pace in 2020.

Hold It!

Canopy growth might not be a wise investment option right now, despite the relatively low price and the market’s bullish outlook on the industry. Experts, in general, recommend hold, with a target price of around $25 that represents a 6% upside on the last closing price. The rating calls for patience on the part of investors while keeping a close watch on the stock for signs of retreat.

Meanwhile, investor confidence remains weak due to factors like the company’s dismal quarterly performance and lack of clarity on Constellation Brands’ (STZ) stake in it, especially after the recent appointment of Constellation executive David Klein as the CEO of Canopy Growth.

New Hope

On the positive side, there is widespread optimism about Klein’s ability to take the company to the growth path. Moreover, the fact that Canopy Growth’s fundamentals are stronger than most of its rivals, including Tilray (TLRY) and Aurora Cannabis (ACB), makes it less risky. Its cash position is exceptionally good and far outweighs the liabilities.

Dismal Q2

In the second quarter, net loss missed the estimates amid cost escalation, though revenues more than doubled and topped the street view reflecting the strong marijuana harvest. Meanwhile, the loss narrowed to C$1.08 per share from last year’s C$1.52 per share loss. Though the outcome took a toll on the stock, it is certainly on the recovery path now.

Also see: Canopy Growth Q1 2020 Earnings Call Transcript

Two months ago, Canopy Growth’s shares slipped a two-year low, continuing the downtrend that started about a year ago that dragged their value by about 25%. However, there are reasons to believe that the bottom is already in. The stock closed the last trading session sharply higher.

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

Share
Published by

Recent Posts

Earnings Summary: Jerash Holdings (US), Inc. posts sharp Q3 FY26 earnings rebound as revenue and margins improve

Jerash Holdings (US), Inc. (NASDAQ: JRSH) reported significantly improved financial results for the fiscal 2026…

48 minutes ago

Prospect Capital Shares Steady Following Fiscal Q2 Adjusted Earnings Beat Despite NAV Decline

Shares of Prospect Capital Corporation (PSEC) traded mixed to slightly positive in early trading on…

8 hours ago

Waters Corporation (WAT) Shares Fall 14.5% Following FY2026 Guidance Despite Q4 Beat

Waters Corporation (WAT) shares dropped 14.49% to $326.04 in early trading on Tuesday after the…

8 hours ago

Universal Corp. (UVV) Shares Plunge 10.7% as Tobacco Volumes, Ingredients Squeeze Earnings

Universal Corp. (UVV) shares fell 10.72% to $51.62 in Tuesday trading after the global agriproducts…

8 hours ago

Upwork Inc (UPWK) Shares Slide Following Soft Q1 Profit Guidance Despite Q4 Beat

Upwork Inc (UPWK) shares fell 4.76% to $17.89 in early trading on Tuesday after the…

9 hours ago

Amkor Q4 2025 Results: Massive AI Boom Drives Growth

Amkor (NASDAQ: AMKR) posted net sales of $1888 million. Amkor Q4 2025 earnings showed robust…

9 hours ago